Nitroso Escitalopram EP Impurity A
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Nitroso Escitalopram EP Impurity A

● In Stock

Catalogue No.:VE007928
CAS No.:N/A
Mol. Formula:C19H20FN3O3
Mol. Weight:357.38 g/mol

Additional information on Nitroso Escitalopram EP Impurity A

Parent drug

Escitalopram

IUPAC Name

1-(4-fluorophenyl)-1-(3-(methyl(nitroso)amino)propyl)-1,3-dihydroisobenzofuran-5-carboxamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(C1=CC2=C(C(CCCN(C)N=O)(C3=CC=C(F)C=C3)OC2)C=C1)N

InChI

InChI=1S/C19H20FN3O3/c1-23(22-25)10-2-9-19(15-4-6-16(20)7-5-15)17-8-3-13(18(21)24)11-14(17)12-26-19/h3-8,11H,2,9-10,12H2,1H3,(H2,21,24)

Description

Nitroso Escitalopram EP Impurity A is an N-nitroso derivative of the secondary amine present in Escitalopram | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Escitalopram production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url